These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36472294)

  • 1. LIVER CIRRHOSIS WITH CRYPTOGENIC GENESES. CLINICAL CASE.
    Horlenko OM; Kossey GB; Pushkarenko OA; Prylypko LB
    Wiad Lek; 2022; 75(10):2536-2540. PubMed ID: 36472294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for cryptogenic cirrhosis.
    Charlton MR; Kondo M; Roberts SK; Steers JL; Krom RA; Wiesner RH
    Liver Transpl Surg; 1997 Jul; 3(4):359-64. PubMed ID: 9346764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases.
    Maor-Kendler Y; Batts KP; Burgart LJ; Wiesner RH; Krom RA; Rosen CB; Charlton MR
    Transplantation; 2000 Jul; 70(2):292-7. PubMed ID: 10933151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome.
    Marmur J; Bergquist A; Stål P
    Scand J Gastroenterol; 2010; 45(1):60-9. PubMed ID: 20030578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
    Younossi Z; Stepanova M; Sanyal AJ; Harrison SA; Ratziu V; Abdelmalek MF; Diehl AM; Caldwell S; Shiffman ML; Schall RA; McColgan B; Subramanian GM; Myers RP; Muir A; Afdhal NH; Bosch J; Goodman Z
    J Hepatol; 2018 Dec; 69(6):1365-1370. PubMed ID: 30144554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
    Nayak NC; Vasdev N; Saigal S; Soin AS
    Hum Pathol; 2010 Mar; 41(3):425-30. PubMed ID: 19954815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
    Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
    Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological Examination of Explanted Liver After Transplantation in Patients With Cryptogenic Cirrhosis.
    Tardu A; Karagul S; Yagci MA; Ertugrul I; Sumer F; Kirmizi S; Yaylak F; Koc C; Hatipoglu S; Kayaalp C; Yilmaz S
    Transplant Proc; 2015 Jun; 47(5):1450-2. PubMed ID: 26093740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes.
    Greeve M; Ferrell L; Kim M; Combs C; Roberts J; Ascher N; Wright TL
    Hepatology; 1993 Apr; 17(4):593-8. PubMed ID: 8386693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic-associated fatty liver disease-related liver cirrhosis and cryptogenic liver cirrhosis].
    Song Y; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):213-215. PubMed ID: 33902187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): a long-term documentation before and after OLT.
    Berg T; Neuhaus R; Klein R; Leder K; Lobeck H; Bechstein WO; Müller AR; Wiedenmann B; Hopf U; Berg PA; Neuhaus P
    Transplantation; 2002 Sep; 74(6):792-8. PubMed ID: 12364857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NASH and cryptogenic cirrhosis: a histological analysis.
    Caldwell SH; Lee VD; Kleiner DE; Al-Osaimi AM; Argo CK; Northup PG; Berg CL
    Ann Hepatol; 2009; 8(4):346-52. PubMed ID: 20009134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Transplantation in Patients with Cryptogenic Cirrhosis Provides Excellent Long-Term Outcome.
    Masior Ł; Grąt M; Krasnodębski M; Patkowski W; Krawczyk M
    Ann Transplant; 2016 Mar; 21():160-6. PubMed ID: 26983869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M; Neuberger JM; Gunson BK; Hübscher SG
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of hepatitis G virus within liver tissue of patients undergoing liver transplantation for cryptogenic cirrhosis.
    Schiano TD; Fiel MI; Abe K; Thung SN; Bodenheimer HC
    Transplantation; 1999 Apr; 67(8):1193-7. PubMed ID: 10232575
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.